Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

I already know that based on my due thorough due diligence, IPIX will have great results proving that amplification of Bril reduces viral of SARsCoV2 viral load and inhibits cytokines and chemokines storm to show its anti-inflammatory properties, again. The human lung epithelial cells should confirm this as well. Take notes! There are five bullet points altogether: EC50, multiple dosing, combo, and etc., etc.

I'm ready for the company to announce when they intend to initiate human trials here in the US and Europe: PIIB/PIII.
And since Bril is a middle stage asset that has ALREADY PROVEN ITS SAFETY AND EFFICACY IN AT LEAST THREE CLINICAL PIPELINE trials, I'd not be shocked if we get more than 60mil from the government to commercialize this drug? IM vaccines are getting an average of 384mil average funding, so a therapeutic could garner as much as 1/3 of the aforementioned dollar amount. Jmo. Remdesivir and other protease inhibitors are ineffective out there, so more options are needed. Bril has at least three shots on goal, if not four.

Below is a good read:

"So far, more than 130 clinical trials of potential COVID-19 related drugs and biological products are underway with FDA oversight and additional development programs for other agents are in the planning stages. These include studies on therapies such as antiviral drugs to keep viruses from multiplying, as well as therapies called immunomodulators aimed at tamping down the body’s own immune reaction to the virus, in cases where the body starts attacking the patient’s own organs. Studies like these, which are conducted by the pharmaceutical industry and academic researchers, assess the products’ toxicity and help to find out if they work against COVID-19. The FDA has started to receive data from clinical studies and expects to receive more data regarding investigational products soon. The agency intends to engage with pharmaceutical sponsors and other government partners to facilitate patient access as soon as possible when favorable results are observed.

The guidances issued today build on steps the agency has taken to streamline its review and advice process to get studies started as quickly as possible, and they incorporate information provided to individual innovators or researchers over the past several months."

Own this success bulls! Lastly, thanks for the business for those who bet against TIH AND IPIX's BRIL!

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment